HOUSTON, March 3, 2026 /PRNewswire/ -- The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighting the ...
To support global influenza vaccine research and development, Sino Biological has launched an extensive portfolio of recombinant antigens for the 2026-2027 Northern Hemisphere influenza vaccine ...
The EMA approved Moderna's mRNA COVID-19 and flu vaccine, but US political battles and funding cuts threaten the future of mRNA vaccine innovation. Talha Burki reports.
Fact checked by Jennifer Klump For years, researchers have sought to develop a vaccine that can protect against any current or future influenza virus variants, including those that have the potential ...
The COVID-19 response has exposed gaps in pandemic preparedness and revealed opportunities to enhance global vaccine development by leveraging novel technologies and streamlining research efforts. At ...